LAPTM4B and breast carcinoma: LAPTM4B is tetratransmembrane lysosomal protein that is overexpressed and associated with poor prognosis in various malignancies including breast cancer, gallbladder cancer, ovarian cancer, HCC, gastric cancer and cervical cancer [7–15].